12-Year Outcomes Following Permanent Prostate Brachytherapy in Patients with Clinically Localized Prostate Cancer

Journal of Urology

Volumn 179, Issue 5 SUPPL., 2008, Pages

  Potters, Louis ^a   Morgenstern, Carol ^a   Calugaru, Emil ^a   Fearn, Paul ^a   Jassal, Anup ^a   Presser, Joseph ^a   Mullen, Edward ^a  

^a SOUTH NASSAU COMMUNITIES HOSPITAL   (United States)

Author keywords

brachytherapy; prostate; prostate specific antigen; prostatic neoplasms; radiometry

Indexed keywords

ANTIANDROGEN; GONADORELIN AGONIST; IODINE 125; PALLADIUM 103; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; GLEASON SCORE; HORMONAL THERAPY; HUMAN; KAPLAN MEIER METHOD; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSTATE BIOPSY; PROSTATE CANCER; RADIATION DOSE; RISK ASSESSMENT;

EID: 41849100029     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2008.03.133     Document Type: Article

References (21)

1. J.C. Blasko T. Mate J.E. Sylvester P.D. Grimm W. Cavanagh Brachytherapy for carcinoma of the prostate: techniques, patient selection, and clinical outcomes Semin Radiat Oncol 12 2002 81
2. L. Potters P. Fearn M.W. Kattan External radiotherapy and permanent prostate brachytherapy in patients with localized prostate cancer Brachytherapy 1 2002 36
3. I. Fleming J.S. Cooper D.E. Henson R.V.P. Huttler B.J. Kennedy G.P. Murphy AJCC Cancer Staging Manual 5th ed. 1997 Lippincott-Raven Philadelphia
4. S. Nag D. Beyer J. Friedland P. Grimm R. Nath American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer Int J Radiat Oncol Biol Phys 44 1999 789
5. D. Beyer R. Nath W. Butler G. Merrick J. Blasko S. Nag American Brachytherapy Society recommendations for clinical implementation of NIST-1999 standards for (103)palladium brachytherapy The clinical research committee of the American Brachytherapy Society Int J Radiat Oncol Biol Phys 47 2000 273
6. R. Nath L.L. Anderson G. Luxton K.A. Weaver J.F. Williamson A.S. Meigooni Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43 American Association of Physicists in Medicine Med Phys 22 1995 209
7. Consensus statement: Guidelines for PSA following radiation therapy American Society for Therapeutic Radiology and Oncology Consensus Panel Int J Radiat Oncol Biol Phys 37 1997 1035
8. M.W. Kattan P.A. Fearn S. Leibel L. Potters The definition of biochemical failure in patients treated with definitive radiotherapy Int J Radiat Oncol Biol Phys 48 2000 1469
9. H. Thames D. Kuban L. Levy E.M. Horwitz P. Kupelian A. Martinez Comparison of alternative biochemical failure definitions based on clinical outcome in 4839 prostate cancer patients treated by external beam radiotherapy between 1986 and 1995 Int J Radiat Oncol Biol Phys 57 2003 929
10. D.R. Cox R. Abadir Regression models and life tables J Roy Statist Soc 34 1972 187
11. E.L. Kaplan P. Meier Nonparametric estimation from incomplete observations J Cancer Res Clin Oncol 53 1958 457
12. P.D. Grimm J.C. Blasko J.E. Sylvester R.M. Meier W. Cavanagh 10-year biochemical (prostate-specific antigen) control of prostate cancer with (125)I brachytherapy Int J Radiat Oncol Biol Phys 51 2001 31
13. H. Ragde G.L. Grado B.S. Nadir Brachytherapy for clinically localized prostate cancer: thirteen-year disease-free survival of 769 consecutive prostate cancer patients treated with permanent implants alone Arch Esp Urol 54 2001 739
14. R.G. Stock N.N. Stone A. Tabert C. Iannuzzi J.K. De Wyngaert A dose-response study for I-125 prostate implants Int J Radiat Oncol Biol Phys 41 1998 101
15. L. Potters Y. Cao E. Calugaru T. Torre P. Fearn X.H. Wang A comprehensive review of CT-based dosimetry parameters and biochemical control in patients treated with permanent prostate brachytherapy Int J Radiat Oncol Biol Phys 50 2001 605
16. F.M. Waterman A.P. Dicker Impact of postimplant edema on V(100) and D(90) in prostate brachytherapy: can implant quality be predicted on day 0? Int J Radiat Oncol Biol Phys 53 2002 610
17. M. Roach 3rd M. DeSilvio C. Lawton V. Uhl M. Machtay M.J. Seider Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413 J Clin Oncol 21 2003 1904
18. J. Sylvester J.C. Blasko P.D. Grimm R. Meier W. Cavanagh Short-course androgen ablation combined with external-beam radiation therapy and low-dose-rate permanent brachytherapy in early-stage prostate cancer: a matched subset analysis Mol Urol 4 2000 155
19. M. Roach 3rd J. Lu M.V. Pilepich S.O. Asbell M. Mohiuddin R. Terry Predicting long-term survival, and the need for hormonal therapy: a meta-analysis of RTOG prostate cancer trials Int J Radiat Oncol Biol Phys 47 2000 617
20. A.V. D’Amico K. Cote M. Loffredo A.A. Renshaw D. Schultz Determinants of prostate cancer-specific survival after radiation therapy for patients with clinically localized prostate cancer J Clin Oncol 20 2002 4567
21. M. Han A.W. Partin C.R. Pound J.I. Epstein P.C. Walsh Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy: The 15-year Johns Hopkins experience Urol Clin North Am 28 2001 555